Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0130 USD
−4.69 M USD
11.57 M USD
152.98 M
About Abingdon Health PLC
Sector
Industry
Website
Headquarters
York
Founded
2008
ISIN
GB00BLF79J41
FIGI
BBG010JMJG03
Abingdon Health Plc engages in the development, manufacturing, and distribution of diagnostic devices and provides consultancy services to businesses in the diagnostics sector. It operates through the following segments: Contract Development Services, Contract Manufacturing, Products Sales, and Regulatory Services. The Contract Development Services segment refers to milestone-based development work for third parties. The Contract Manufacturing segment includes contract development. The Product Sales segment comprises the sale of AbC-19TM, Pocket Diagnostic products, PCRD tests, and antibodies for research use. The Regulatory Services segment involves customer support for compliance requirements in international IVD and medical device markets. The company was founded by Brett David Pollard, Chris Henry Francis Yates, and Christopher William Hand on January 16, 2008 and is headquartered in York, the United Kingdom.
Related stocks
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Abingdon Health Ltd. stocks are traded under the ticker ABDXF.
ABDXF reached its all-time high on Aug 19, 2022 with the price of 0.0700 USD, and its all-time low was 0.0700 USD and was reached on Aug 19, 2022. View more price dynamics on ABDXF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ABDXF stock is 0.00% volatile and has beta coefficient of −0.22. Track Abingdon Health Ltd. stock price on the chart and check out the list of the most volatile stocks — is Abingdon Health Ltd. there?
Today Abingdon Health Ltd. has the market capitalization of 22.58 M, it has decreased by −22.94% over the last week.
Yes, you can track Abingdon Health Ltd. financials in yearly and quarterly reports right on TradingView.
Abingdon Health Ltd. is going to release the next earnings report on Apr 1, 2026. Keep track of upcoming events with our Earnings Calendar.
ABDXF net income for the last half-year is −1.23 M USD, while the previous report showed −3.15 M USD of net income which accounts for 61.09% change. Track more Abingdon Health Ltd. financial stats to get the full picture.
No, ABDXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Abingdon Health Ltd. EBITDA is −4.49 M USD, and current EBITDA margin is −40.54%. See more stats in Abingdon Health Ltd. financial statements.
Like other stocks, ABDXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Abingdon Health Ltd. stock right from TradingView charts — choose your broker and connect to your account.